1. Home
  2. RDY vs HST Comparison

RDY vs HST Comparison

Compare RDY & HST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • HST
  • Stock Information
  • Founded
  • RDY 1984
  • HST 1927
  • Country
  • RDY India
  • HST United States
  • Employees
  • RDY N/A
  • HST N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • HST Real Estate Investment Trusts
  • Sector
  • RDY Health Care
  • HST Real Estate
  • Exchange
  • RDY Nasdaq
  • HST Nasdaq
  • Market Cap
  • RDY 11.6B
  • HST 10.0B
  • IPO Year
  • RDY N/A
  • HST N/A
  • Fundamental
  • Price
  • RDY $13.88
  • HST $17.55
  • Analyst Decision
  • RDY Strong Buy
  • HST Buy
  • Analyst Count
  • RDY 1
  • HST 13
  • Target Price
  • RDY $16.90
  • HST $18.50
  • AVG Volume (30 Days)
  • RDY 1.1M
  • HST 9.3M
  • Earning Date
  • RDY 10-24-2025
  • HST 11-05-2025
  • Dividend Yield
  • RDY 0.52%
  • HST 5.12%
  • EPS Growth
  • RDY 9.95
  • HST 3.27
  • EPS
  • RDY 0.79
  • HST 1.06
  • Revenue
  • RDY $3,851,623,984.00
  • HST $5,950,000,000.00
  • Revenue This Year
  • RDY $6.29
  • HST $6.48
  • Revenue Next Year
  • RDY $2.61
  • HST $1.70
  • P/E Ratio
  • RDY $17.55
  • HST $16.60
  • Revenue Growth
  • RDY 14.10
  • HST 6.44
  • 52 Week Low
  • RDY $12.26
  • HST $12.22
  • 52 Week High
  • RDY $16.17
  • HST $19.37
  • Technical
  • Relative Strength Index (RSI)
  • RDY 49.14
  • HST 58.37
  • Support Level
  • RDY $13.37
  • HST $15.61
  • Resistance Level
  • RDY $13.52
  • HST $18.23
  • Average True Range (ATR)
  • RDY 0.24
  • HST 0.47
  • MACD
  • RDY 0.02
  • HST 0.19
  • Stochastic Oscillator
  • RDY 49.31
  • HST 72.33

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About HST Host Hotels & Resorts Inc.

Host Hotels & Resorts owns 81 predominantly urban and resort upper-upscale and luxury hotel properties representing over 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.

Share on Social Networks: